Sakina Davis, MD - Hashimotos and LDN (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

The LDN Side Effect Survey Results from 2020 - Jill Brook, MA (2021 Conference) (LDN, low dose naltrexone)

Jill Brook, MA is a Research Advisor to the LDN Research Trust. In this presentation she shares the results of the 2020 LDN Side Effect Survey.

Hypothyroidism - Dawn Ipsen, PharmD (2021 Conference) (LDN, low dose naltrexone)

Dr. Dawn Ipsen is a compounding pharmacist who presents on some roles low dose naltrexone (LDN) may have in helping patients with hypothyroidism. She discusses hypothyroidism, its prevalence, and treatment goals. 

Autoimmune thyroiditis Part 3 - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)

This is Part 3 of Dr. Holtorf’s 3-part series on autoimmune thyroiditis as a core cause of hypothalamic pituitary dysfunction, mitochondrial dysfunction, obesity and systemic illness. This last segment will bring it all together and give practical ways to use this information.